Optical Coherence Tomography Angiography Characteristics of Polypoidal Lesions in Caucasians

Table 3

Univariate values (and CI 95% for odds ratios) of covariables potentially influencing the characteristics of polypoidal lesions in SS-OCTA.

Variables	SS-OCTA B-scan (diffuse vs. circumscribed flow)	SS-OCTA en face (tangled vessel balls vs. others)
Sex	0.0783 (0.789–43.17)	0.8902 (0.191–4.295)
Laterality	0.6831 (0.084–5.372)	0.5011 (0.123–2.967)
Age	0.227 (0.959–1.174)	0.8347 (0.934–1.086)
BCVA at baseline	0.0778 (0.649–>999)	0.1587 (0.011–2.302)
Pachychoroid disease vs. AMD	0.999 (0.031–32.14)	0.5186 (0.114–3.196)
Idiopathic disease vs. AMD	0.777 (0.049–50.665)	0.5152 (0.130–46.514)
Presence of hemorrhage	0.9615 (0.128–7.137)	0.9848 (0.209–4.925)
Prior treatment with anti-VEGF	0.1591 (0.505–39.416)	0.4068 (0.108–2.649)
PED height	0.1509 (0.986–1.003)	0.6095 (0.997–1.004)
PED configuration 1 vs. 0	0.5869 (0.049–6.031)	0.4144 (0.317–13.056)
PED configuration 2 vs. 0^†	0.6694 (0.026–11.69)	0.9601 (0.317–13.056)
SFCT	0.1653 (0.986–1.003)	0.1798 (0.997–1.012)
SFCT of contralateral eye	0.3875 (0.986–1.006)	0.1642 (0.997–1.014)

SS-OCTA = swept source optical coherence tomography angiography; BCVA = best corrected visual acuity; AMD = age-related macular degeneration; MNV = macular neovascularization type 1; anti-VEGF = antivascular endothelial growth factor; PED = pigment epithelial detachment; PED configuration 0 = sharp-peaked PED; PED configuration 1 = below the top of a PED; ^†PED configuration 2 = adjacent to a PED notch; SFCT = subfoveal choroidal thickness.